Dr. Terri Pustilnik, M.D.
What this data tells you about Dr. Pustilnik
Dr. Terri Pustilnik is a gynecologic oncology physician in Webster, TX, with 20 years in practice. Based on federal Medicare data, Dr. Pustilnik performed 70,308 Medicare services across 895 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pustilnik received a total of $123,329 from 26 pharmaceutical and/or device companies across 150 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pustilnik is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 45,390 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) | 7,050 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 5,200 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia | 5,145 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 4,682 | $0 | $3 |
| Dexamethasone injection (steroid) | 639 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 550 | $1 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 187 | $23 | $157 |
| Blood draw (venipuncture) | 134 | $8 | $20 |
| Administration of chemotherapy into vein, 1 hour or less | 129 | $103 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 122 | $51 | $313 |
| Complete blood count (CBC) with differential | 113 | $8 | $36 |
| Injection, carboplatin, 50 mg | 113 | $2 | $300 |
| Injection, zoledronic acid, 1 mg | 86 | $6 | $431 |
| Injection of additional new drug or substance into vein | 82 | $12 | $108 |
| Drug injection, under skin or into muscle | 79 | $11 | $96 |
| Office visit, established patient (20-29 min) | 72 | $67 | $250 |
| Administration of chemotherapy into vein, each additional hour | 65 | $23 | $161 |
| Comprehensive metabolic blood panel | 64 | $10 | $64 |
| Administration of additional new drug or substance into vein, 1 hour or less | 62 | $52 | $344 |
| Office visit, established patient (10-19 min) | 55 | $38 | $150 |
| CT scan of abdomen and pelvis with contrast | 45 | $182 | $1,067 |
| Ct scan of chest with contrast | 39 | $54 | $821 |
| Injection, diphenhydramine hcl, up to 50 mg | 36 | $1 | $7 |
| New patient office visit (45-59 min) | 34 | $129 | $565 |
| Unclassified drugs | 29 | $1 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 27 | $16 | $94 |
| Office visit, established patient (30-39 min) | 21 | $103 | $368 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 20 | $1,144 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 20 | $91 | $657 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 18 | $750 | $3,096 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gynecologic oncology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for gynecologic oncology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pustilnik is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 8%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pustilnik experienced with iron infusion (feraheme)?
Does Dr. Pustilnik receive payments from pharmaceutical companies?
How do Dr. Pustilnik's costs compare to other gynecologic oncology physicians in Webster?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology